Drs Martin and Sylvester were the first to take advantage of Dr. Lane’s p53 monoclonal antibodies and investigate by immunohistochemistry the correlation between the p53 protein level and a GC patient’s prognosis [105]. This evidence concerns the gene TP53 and gastric cancer.